{
    "2021-11-24": [
        [
            {
                "time": "",
                "original_text": "北上资金今日净买入五粮液12.61亿元、贵州茅台10.16亿元，净卖出伊利股份5.97亿元、药明康德2.95亿元。",
                "features": {
                    "keywords": [
                        "北上资金",
                        "净买入",
                        "五粮液",
                        "贵州茅台",
                        "净卖出",
                        "伊利股份",
                        "药明康德"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "白酒",
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "北向资金连续4日净买入累计加仓超170亿，批量扫货白酒股。",
                "features": {
                    "keywords": [
                        "北向资金",
                        "净买入",
                        "加仓",
                        "白酒股"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "白酒"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "江苏区域股股市周报：新增4家上市公司，85家机构调研斯莱克。",
                "features": {
                    "keywords": [
                        "江苏区域",
                        "上市公司",
                        "机构调研",
                        "斯莱克"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "区域经济"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业周报：CDE发布《以临床价值为导向的抗肿瘤药物临床研发指导原则》。",
                "features": {
                    "keywords": [
                        "医药生物",
                        "CDE",
                        "临床价值",
                        "抗肿瘤药物",
                        "研发指导原则"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "覆盖强生、默沙东等大客户，药明康德等CXO龙头股境外收入占比已超50%。",
                "features": {
                    "keywords": [
                        "药明康德",
                        "CXO",
                        "龙头股",
                        "境外收入",
                        "强生",
                        "默沙东"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "前沿 | 合全药业与阿斯利康联合发表！KRAS抑制剂原料药工艺优化满足大规模生产需求。",
                "features": {
                    "keywords": [
                        "合全药业",
                        "阿斯利康",
                        "KRAS抑制剂",
                        "原料药",
                        "工艺优化",
                        "大规模生产"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "清华大学统计学研究中心胡志睿课题组诚聘博士后，统计学、生物信息学、计算机等相关专业。",
                "features": {
                    "keywords": [
                        "清华大学",
                        "统计学",
                        "胡志睿",
                        "博士后",
                        "生物信息学",
                        "计算机"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "教育",
                        "科研"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}